0
Article ? AI-assigned paper type based on the abstract. Classification may not be perfect — flag errors using the feedback button. Tier 2 ? Original research — experimental, observational, or case-control study. Direct primary evidence. Human Health Effects Nanoplastics Reproductive & Development Sign in to save

Detection of Microplastic in Human Placenta and Meconium in a Clinical Setting

Pharmaceutics 2021 438 citations ? Citation count from OpenAlex, updated daily. May differ slightly from the publisher's own count. Score: 65 ? 0–100 AI score estimating relevance to the microplastics field. Papers below 30 are filtered from public browse.
Thorsten Braun, Ievgeniia Lomako, Ievgeniia Lomako, Philipp Schwabl Philipp Schwabl Ievgeniia Lomako, Ievgeniia Lomako, Loreen Ehrlich, Ievgeniia Lomako, B. Liebmann, Loreen Ehrlich, Ievgeniia Lomako, Wolfgang Henrich, B. Liebmann, Sebastian Koeppel, Sebastian Koeppel, Sebastian Koeppel, Sebastian Koeppel, Ievgeniia Lomako, B. Liebmann, Sebastian Koeppel, Ievgeniia Lomako, Philipp Schwabl Ievgeniia Lomako, Ievgeniia Lomako, B. Liebmann, Ievgeniia Lomako, B. Liebmann, B. Liebmann, Ievgeniia Lomako, Philipp Schwabl

Summary

Researchers detected microplastic particles larger than 50 micrometers in human placenta and meconium (a baby's first stool) collected during cesarean deliveries. This is significant because it provides direct evidence that microplastics are present in the womb and are being passed to babies before and during birth. The study emphasizes the need for careful contamination controls in clinical studies and calls for further research on nano-sized plastics in human tissue.

Body Systems

We found MPs > 50 µm in placenta and meconium acquired from cesarean delivery. Critical evaluation of potential contamination sources is pivotal and may guide future clinical studies to improve the correct detection of MPs in organ tissue. Studies investigating nano-sized plastics in human tissue are warranted.

Sign in to start a discussion.

Share this paper